Skip to main content

8 August 2001

Portex, Inc., Keene, NH announces the acquisition of the Point-Lok Needle Protection Device from Griff Industries, Chatsworth, CA. The Point-Lok device is a versatile, stand-alone protection product that can be used on a variety of needle types and sizes. Portex has been marketing the product separately and packaged with its Arterial Blood Gas Sampling kits for several years. It has now purchased the rights to manufacture the product and other assets from Griff Industries.

Jeff Spielman, President of Portex, Inc. commented We are delighted to have made this acquisition, which will help to secure our position in the rapidly expanding needle protection device market. Portex, Inc. has invested in this area for a number of years and the results of that investment are now being realized in strong profit growth. We see the Point-Lok transaction as one of several moves to expand our Needle-Pro needle protection product range from the simplest devices to more complex, engineered protection products.

Headquartered in Keene, New Hampshire, Portex, Inc. is part of Smiths Group plc, London, and manufactures a wide range of single-use medical devices for the worldwide market.

ENDS

General media enquiries

Contact our global media and communications team at:

Tom Steiner

Tom Steiner

Head of External Communications

+44 (0) 20 7004 1600

Email Arrow right icon
Charlotte Bulmer

Charlotte Bulmer

Corporate Communications Executive

+44 (0) 20 7004 1600

Email Arrow right icon

Please note – the press team can only answer enquiries from accredited members of the press.

Related articles

Earth View

Response to shareholder letter

Find out more Call to action arrow icon
Japan Airport

Smiths Detection expands partnership with Fukuoka International Airport

Smiths Detection, part of Smiths Group, provides 3D X-ray technology to help speed passengers speed through security at Fukuoka International Airport.

Find out more Call to action arrow icon
Cityscape

Appointment of Chief Financial Officer and upgraded FY2025 guidance

Find out more Call to action arrow icon
Sign up for updates Call to action arrow icon